Avanos Medical AVNS Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount.
The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's valuation allowance, deferred tax asset, increase (decrease), amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's valuation allowance, deferred tax asset, increase (decrease), amount?
- Avanos Medical (AVNS) reported valuation allowance, deferred tax asset, increase (decrease), amount of $200K in Q4 2025.
- How has Avanos Medical's valuation allowance, deferred tax asset, increase (decrease), amount changed year-over-year?
- Avanos Medical's valuation allowance, deferred tax asset, increase (decrease), amount increased by 300.0% year-over-year, from -$100K to $200K.
- What is the long-term trend for Avanos Medical's valuation allowance, deferred tax asset, increase (decrease), amount?
- Over 4 years (2021 to 2025), Avanos Medical's valuation allowance, deferred tax asset, increase (decrease), amount has grown at a -13.1% compound annual growth rate (CAGR), from $1.4M to $800K.
- What does valuation allowance, deferred tax asset, increase (decrease), amount mean?
- Measures the change in the valuation allowance established against deferred tax assets, indicating management's assessment of the recoverability of these assets. An increase in the allowance suggests reduced confidence in realizing future tax benefits, often due to sustained operating losses. This serves as a key indicator of financial health and future tax planning flexibility.